For research use only
| Cat No. | ABC-RC001Y |
| Product Type | Recombinase Stable Cell Line |
| Cell Type | Epithelial |
| Species | Mouse |
| Host Cell | KLN205 |
| Source Organ | Lung |
| Disease | Squamous Cell Carcinoma |
| Storage | Liquid Nitrogen |
KLN205/Cre Stable Cell Line by AcceGen delivers reliable Cre recombinase expression for conditional gene knockout and cancer research applications.
KLN205/Cre Stable Cell Line is a genetically engineered murine lung squamous carcinoma model developed from the KLN205 parental cell line through stable integration of a constitutive Cre recombinase expression cassette. This specialized cell line maintains the characteristic epithelial morphology and tumorigenic properties of KLN205 cells while providing robust, nuclear-localized Cre recombinase activity for precise loxP-mediated genetic modifications. The stable Cre expression enables efficient recombination of floxed alleles, making this cell line particularly valuable for conditional gene knockout studies, lineage tracing experiments, and facilitating conditional gene knockout or activation of floxed oncogenes in lung cancer research. Applications include mechanistic studies of squamous cell carcinoma pathogenesis, evaluation of gene function in tumor progression, and development of genetically engineered cancer models. The cells have undergone rigorous quality control testing and are confirmed free of contamination from mycoplasma, fungi, yeast, and bacteria.
| Species | Mouse |
| Cat.No | ABC-RC001Y |
| Product Category | Transfected Stable Cell Lines |
| Size/Quantity | 1 vial |
| Cell Type | Epithelial |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Lung |
| Disease | Squamous Cell Carcinoma |
| Biosafety Level | 2 |
| Storage | Liquid Nitrogen |
| Product Type | Recombinase Stable Cell Line |
| Host Cell | KLN205 |
| Gene Info | Cre Recombinase |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
The KLN205/Cre Stable Cell Line is a valuable tool for gene function studies and conditional gene editing in cancer research. It enables precise Cre-loxP-mediated recombination, facilitating targeted gene knockout or activation in the KLN205 murine lung squamous carcinoma model. This cell line is particularly useful for investigating tumorigenesis mechanisms, evaluating oncogene functions, and validating drug targets in vitro. Its application extends to preclinical drug screening and therapeutic evaluation, providing a reliable platform for studying lung cancer progression and therapeutic responses under controlled genetic modifications.